QQ客服 官方微博 反馈留言

浏览/检索结果: 共29条，第1-10条 帮助 限定条件 发表日期：2022     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 Analysis of the efficacy and safety of immunotherapy in advanced thymoma patients 期刊论文 CANCER MEDICINE, 2022 作者:  Hao, Yue;  Lin, Gen;  Xiang, Jing;  Wang, Wenxian;  Xu, Chunwei 收藏  |  浏览/下载：15/0  |  提交时间：2022/12/23 efficacy  immune-related adverse events  immunotherapy  thymoma   Cost-effectiveness analysis of drug-eluting beads and conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma 期刊论文 FRONTIERS IN PUBLIC HEALTH, 2022, 卷号: 10 作者:  Shao, Guoliang;  Wang, Jingwen;  Zhou, Xiaoying;  Sun, Guojun;  Dong, Zuojun 收藏  |  浏览/下载：12/0  |  提交时间：2022/12/23 DEB-TACE  cTACE  partition survival model  cost-effectiveness analysis  hepatocellular carcinoma   Whether individualized dose escalation should be recommended for lymph nodes with different sizes in the definitive radiotherapy of cervical cancer? 期刊论文 RADIATION ONCOLOGY, 2022, 卷号: 17 作者:  Lv, Xiaojuan;  Rao, Huiting;  Feng, Tao;  Wu, Chufan;  Lou, Hanmei 收藏  |  浏览/下载：12/0  |  提交时间：2022/12/22 Radiotherapy  Dose escalation  Lymph node  Uterine cervical neoplasms   Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study 期刊论文 EUROPEAN JOURNAL OF CANCER, 2022, 卷号: 174 作者:  Wang, Wenxian;  Lin, Gen;  Guan, Yelan;  Zhang, Yuxin;  Xu, Chunwei 收藏  |  浏览/下载：18/0  |  提交时间：2022/12/23 Thymic carcinoma  Immunotherapy  PD-1  Efficacy  Immune-related adverse events   A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer 期刊论文 THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 卷号: 14 作者:  Yan, Min;  Yuan, Peng;  Ouyang, Quchang;  Cheng, Ying;  Han, Guohui 收藏  |  浏览/下载：24/0  |  提交时间：2022/12/23 breast cancer  chemotherapy  efficacy  lobaplatin  neoplasm metastasis  safety   The Efficacy of PD-1/PD-L1 Inhibitors in Patients with Liver Metastasis of Non-Small Cell Lung Cancer: A Real-World Study 期刊论文 CANCERS, 2022, 卷号: 14 作者:  Xie, Mingying;  Li, Na;  Xu, Xiaoling;  Xu, Yanjun;  Li, Hui 收藏  |  浏览/下载：23/0  |  提交时间：2022/12/22 liver metastasis  non-small cell lung cancer  PD-L1  PD-1  PD-L1 inhibitor  CD8+T cell   Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Li, Ning;  Zhang, Youzhong;  Wang, Jing;  Zhu, Jianqing;  Wang, Li 收藏  |  浏览/下载：26/0  |  提交时间：2022/12/22 Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with conventional taxanes in women with breast cancer: a systematic review and meta-analysis 期刊论文 ANNALS OF PALLIATIVE MEDICINE, 2022, 卷号: 11 作者:  Lei, Lei;  Chen, Rucheng;  Fan, Lei;  Zheng, Weijun;  Wang, Xiaojia 收藏  |  浏览/下载：19/0  |  提交时间：2022/12/23 Breast cancer  nanoparticle-albumin-bound paclitaxel (Nab-P)  taxanes  meta-analysis   Trastuzumab in combination with chemotherapy for HER2-positive metastatic gastric cancer patients underwent conversion therapy 期刊论文 TRANSLATIONAL CANCER RESEARCH, 2022, 卷号: 11 作者:  Zhang, Yanqiang;  Xu, Xiaoqing;  Hu, Can;  Du, Yian;  Ding, Guangyu 收藏  |  浏览/下载：13/0  |  提交时间：2022/12/23 Gastric cancer  HER2-positive  conversion therapy   Maintenance endocrine therapy prolonged progression-free survival of first-line chemotherapy with trastuzumab in advanced HR-positive, HER2-positive breast cancer patients. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Shen, Xia-Bo;  Wu, Jia-Yi;  Chen, Ke-Yu;  Fang, Zi-Ru;  Li, Guang-Liang 收藏  |  浏览/下载：11/0  |  提交时间：2022/12/23